arrow_back Back Filing freshness 10-Q Q3 FY2026 SEC EDGAR

download Export Data

Beta Bionics, Inc.

BBNX

$15.46 ▼ -1.47 (-8.71%) at close

13 Visible periods

24 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Beta Bionics, Inc. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $719.5M

Dividend Yield —

Revenue Growth 30.3% ↘

Op. Margin -74.9% ↗

ROIC -5.2% ↗

FCF / Share $-0.31 ↗

Trailing P/E —

Price / Book 2.1x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Nov 5, 2026.

13-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$35.51M

↑ +30.3% —

Net Income Profit after all expenses

$-24.35M

↓ -71.4% —

Operating Margin Operating profit as % of sales

-74.9%

↑ +6.2% 3th

FCF / Share Free cash flow per share

$-0.31

↑ +11.0% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile
Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↑

Returns

Cash Quality →

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 4 metrics

Metric	Q3 FY2026 Sep 30, 2026 10-Q ↗	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q4 FY2022 Dec 31, 2022 10-K ↗
Revenue Growth YoY (%)	30.3% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+278%)	37.8% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+372%)	56.6% Excellent → Excellent Stable Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+608%)	57.1% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+614%)	63.1% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+689%)	54.4% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+581%)	36.4% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+355%)	—	—	—	—	—	—
EPS Growth YoY (%)	-57.6% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-35.9% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	47.3% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	89.4% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	77.4% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	83.5% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	55.1% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—
Net Income Growth YoY (%)	-71.4% Weak ↓ Weak Declining Year-over-year change in net income	-38.7% Weak ↓ Weak Declining Year-over-year change in net income	23.6% Good ↑ Good Improving Year-over-year change in net income	25.6% Excellent ↑ Excellent Improving Year-over-year change in net income	-45.9% Weak ↑ Weak Improving Year-over-year change in net income	-16.6% Weak Weak Year-over-year change in net income	-130.2% Weak Weak Year-over-year change in net income	—	—	—	—	—	—
FCF Growth YoY (%)	—	—	14.2% Fair Fair Year-over-year change in free cash flow	—	—	—	68.3% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—

💰 Are margins durable? 4 metrics

Metric	Q3 FY2026 Sep 30, 2026 10-Q ↗	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q4 FY2022 Dec 31, 2022 10-K ↗
Operating Margin (%) (%)	-74.9% Weak → Weak Stable Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-600%)	-79.9% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-633%)	-87.9% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-686%)	-50.2% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-435%)	-62.5% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-517%)	-85.5% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-670%)	-105.7% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-805%)	-63.8% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-525%)	-65.7% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-538%)	-78.3% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-622%)	-73.1% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-587%)	—	—
Profit Margin (%) (%)	-68.6% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-672%)	-73.1% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-709%)	-79.3% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-760%)	-41.9% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-449%)	-52.1% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-534%)	-72.6% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-705%)	-162.5% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1454%)	-88.6% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-838%)	-58.3% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-586%)	-96.1% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-901%)	-96.3% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-902%)	—	—
FCF Margin (%) (%)	-41.0% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-48.9% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-91.3% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-32.8% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	-115.1% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-72.6% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-69.0% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-84.7% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-97.0% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—
FCF / Net Income (x)	0.60x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.67x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.15x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	0.78x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.71x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.82x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.18x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.88x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	1.01x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q3 FY2026 Sep 30, 2026 10-Q ↗	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q4 FY2022 Dec 31, 2022 10-K ↗
Return on Invested Capital (%)	-5.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-7.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-7.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-4.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-4.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-5.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-4.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	4.2% Caution ↑ Caution Improving Return earned on debt + equity capital invested Optimal: > 10%	3.8% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	4.2% Caution Caution Return earned on debt + equity capital invested Optimal: > 10%	3.5% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—
Return on Capital (%) (%)	-6.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-8.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-8.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-4.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-5.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-6.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-5.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	-8.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—	—
Return on Common Equity (%) (%)	-6.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-140%)	-9.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-161%)	-8.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-154%)	-4.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-131%)	-4.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-132%)	-5.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-137%)	-9.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-161%)	7.4% Caution ↑ Caution Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-51%)	4.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-72%)	6.5% Caution Caution Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-56%)	5.8% Caution Caution Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-61%)	—	—

⚖️ Is the balance sheet risky? 1 metrics

Metric	Q3 FY2026 Sep 30, 2026 10-Q ↗	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q4 FY2022 Dec 31, 2022 10-K ↗
Net Debt (USD)	$-81.55M	$-44.32M	$-30.21M	$-31.58M	$-38.48M	$-35.08M	$-42.45M	$-30.43M	$-17.48M	$-13.03M	$-22.07M	$-26.57M	—

📊 What does each share earn? 6 metrics

Metric	Q3 FY2026 Sep 30, 2026 10-Q ↗	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q4 FY2022 Dec 31, 2022 10-K ↗
Revenue per Share (USD)	$0.76	$0.72	$0.62	—	$0.62	$0.54	$0.57	—	$2.51	$2.46	$2.15	—	—
Basic EPS, GAAP (USD)	$-0.52	$-0.53	$-0.49	$-0.29	$-0.33	$-0.39	$-0.93	$-2.74	$-1.46	$-2.37	$-2.07	—	—
Free Cash Flow per Share (USD)	$-0.31	$-0.35	$-0.57	—	—	—	$-0.66	—	$-1.73	$-2.09	$-2.08	—	—
Book Value per Share (USD)	$7.38	$5.70	$6.09	$6.48	$6.70	$6.94	$7.24	$-36.80	$-34.36	$-36.23	$-35.59	—	—
Tangible Book Value per Share (USD)	$7.38	$5.70	$6.09	$6.48	$6.70	$6.94	$7.24	$-36.80	$-34.36	$-36.23	$-35.59	—	—
Basic Weighted Avg Shares (shares)	46.54M	44.55M	44.44M	—	43.63M	43.39M	30.71M	—	6.66M	6.11M	6.02M	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q3 FY2026 Sep 30, 2026 10-Q ↗	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q4 FY2022 Dec 31, 2022 10-K ↗
Working Capital (USD)	$260.11M	$205.02M	$224.79M	$236.98M	$244.64M	$266.59M	$245.42M	$111.78M	—	—	—	$93.02M	—
Total Equity (USD)	$401.38M	$256.37M	$271.25M	$287.61M	$294.76M	$301.63M	$313.75M	$-245.36M	$-228.85M	$-221.21M	$-214.32M	$-203.10M	$-170.03M

📋 What is driving earnings? 4 metrics

Metric	Q3 FY2026 Sep 30, 2026 10-Q ↗	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q4 FY2022 Dec 31, 2022 10-K ↗
Sales/Revenue/Turnover (USD)	$35.51M	$32.01M	$27.63M	$32.12M	$27.25M	$23.24M	$17.64M	$20.44M	$16.70M	$15.05M	$12.93M	—	—
Depreciation Expense (USD)	$892.00K	$709.00K	$585.00K	$538.00K	—	—	$303.00K	$232.00K	$333.00K	$299.00K	$287.00K	—	—
Net Income, GAAP (USD)	$-24.35M	$-23.40M	$-21.89M	$-13.47M	$-14.21M	$-16.87M	$-28.66M	$-18.11M	$-9.74M	$-14.46M	$-12.45M	—	—
Operating Cash Flow (USD)	$-12.29M	$-14.62M	$-23.83M	$-8.63M	—	—	$-19.98M	$-14.28M	$-9.61M	$-12.24M	$-12.14M	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 4 years · 13 quarters

Beta Bionics, Inc.

Analytical Summary

13-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare BBNX with peers